Diabetes

A global meta-analysis shows people with mental disorders receive poorer diabetes monitoring and less access to newer therapies.

A major review links PFAS exposure to higher gestational diabetes risk, highlighting environmental chemicals as emerging pregnancy health concerns.

Among 469 circulating metabolites assessed, 235 were significantly associated with incident disease. Notably, 67 of these associations had not been previously reported.

Large cohort study links higher exposure to several food preservatives with increased type 2 diabetes incidence, prompting calls for safety review.

Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk.

Mazdutide, a dual glucagon and GLP-1 agonist, delivers greater HbA1c and weight reductions than dulaglutide in people with type 2 diabetes.

PUFA-rich and Nordic diets reduce liver fat and LDL cholesterol over 12 months, with broader metabolic benefits seen with the Nordic diet.

Global modelling study shows the economic burden of diabetes could reach trillions by 2050, with informal caregiving a major, under-recognised cost driver.